Upgrade to SI Premium - Free Trial

Alnylam Pharma (ALNY) Tops Q3 EPS by 54c

October 31, 2019 8:01 AM
Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.50), $0.54 better than the analyst estimate of ($2.04). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles